Analyst Consensus ?
ConsensusBuy64 ratings
Bullish5179.7%
Neutral1117.2%
Bearish23.1%
Meta Platforms, Inc. · META · FY2025 Q3 · Calendar Q4 2025
Meta Q3: Strong ad growth meets accelerating AI investment
The quarter supports a constructive but qualified view of Meta's growth trajectory: resilient advertising demand and improving AI-driven engagement provide evidence for continued growth, while the payoff from sharply higher AI investment remains unproven and carries execution, margin, regulatory, and seasonality risks.
Reported After market closeNASDAQCommunication Services
$1854.77B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$7.25
Consensus $6.72
EPS surprise
+7.9%
Reported versus consensus
Reported revenue
$51.24B
Consensus $49.51B
Revenue surprise
+3.5%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-11.3%
Event window
SPY move
-1.1%
Same window
Abnormal move
-10.2%
Stock minus SPY
Volume
7.2×
Versus trailing sessions
Subsequent drift
-2.8%
Up to 20 sessions
METASPY benchmark
Ask FN2 about META FY2025 Q3
Transcript, numbers and history already loaded
Why did META fall 11.3% after beating EPS estimates in FY2025 Q3?What changed in META's guidance and outlook in FY2025 Q3?Give me the bull and bear case for META after FY2025 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Versus the prior-quarter analysis, Meta reported faster revenue growth, expanded its AI product and model roadmap, and made the scale of infrastructure financing more explicit through the Blue Owl joint venture. The new analysis also highlights a near-term Q4 Reality Labs headwind from lapping the Quest 3S launch, alongside continued regulatory and capex concerns.
Guidance delta
Maintained; management emphasized continued investment in AI compute, data centers, products, and advertising automation.
Key takeaways
- Q3 revenue rose 26% year over year, driven by strong advertising growth and video engagement.
- Management highlighted AI-powered recommendations, Advantage+ automation, Meta AI, and AI glasses as growth drivers.
- AI infrastructure investment is accelerating; a Blue Owl joint venture is intended to fund future data-center builds.
- Reality Labs revenue grew 74% year over year in Q3, but management flagged a Q4 headwind from lapping the Quest 3S launch.
- The central tension is whether AI investment can sustain growth while capex, expenses, regulatory scrutiny, and product-seasonality risks rise.
Management priorities
- Scale AI compute and data-center capacity, including through the Blue Owl joint venture.
- Advance frontier AI models and integrate them across Meta's family of apps.
- Expand Advantage+ automated advertising and improve ad conversion and efficiency.
- Scale AI glasses and next-generation Ray-Ban and Oakley devices.
- Develop Meta AI, Vibes, and other AI-created content experiences.
Follow META with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$728.08Current
$105Low
$543.55Average
$950High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Arete | Buy | Neutral | Upgrade | Jun 2, 2026 |
| JP Morgan | Neutral | Overweight | Downgrade | Apr 30, 2026 |
| Erste Group | Hold | Buy | Downgrade | Apr 2, 2026 |
| Wolfe Research | Outperform | Outperform | Maintain | Jan 29, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Jan 29, 2026 |
| UBS | Buy | Buy | Maintain | Jan 29, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Jan 29, 2026 |
| Roth Capital | Buy | Buy | Maintain | Jan 29, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jan 29, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 29, 2026 |
| Jefferies | Buy | Buy | Maintain | Jan 29, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jan 29, 2026 |
| Evercore ISI | Outperform | Outperform | Maintain | Jan 29, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Jan 29, 2026 |
| Citigroup | Outperform | Outperform | Maintain | Jan 29, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jan 29, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jan 29, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jan 29, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jan 29, 2026 |
| Rothschild & Co Redburn | Buy | Neutral | Upgrade | Jan 26, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jan 26, 2026 |
| KeyBanc | Overweight | Overweight | Maintain | Jan 26, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jan 23, 2026 |
| Cowen & Co. | Buy | Buy | Maintain | Jan 13, 2026 |
| Exane BNP Paribas | Outperform | - | - | Nov 24, 2025 |
| The Benchmark Company | Hold | Buy | Downgrade | Oct 30, 2025 |
| Stifel | Buy | Buy | Maintain | Oct 30, 2025 |
| Seaport Global | Buy | Buy | Maintain | Oct 30, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 30, 2025 |
| Oppenheimer | Perform | Outperform | Downgrade | Oct 30, 2025 |
| Monness Crespi Hardt | Buy | Buy | Maintain | Oct 30, 2025 |
| Mizuho | Outperform | Outperform | Maintain | Oct 30, 2025 |
| Benchmark | Hold | Buy | Downgrade | Oct 30, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 30, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 14, 2025 |
| Loop Capital Markets | Buy | Buy | Maintain | Aug 5, 2025 |
| Canaccord Genuity | Buy | Buy | Maintain | Jul 16, 2025 |
| Needham | Hold | Underperform | Upgrade | Jul 3, 2025 |
| Susquehanna | Positive | Positive | Maintain | May 1, 2025 |
| Tigress Financial | Strong Buy | Strong Buy | Maintain | Feb 11, 2025 |
| Pivotal Research | Buy | Buy | Maintain | Jan 30, 2025 |
| JMP Securities | Outperform | Outperform | Maintain | Jan 2, 2025 |
| Monness, Crespi, Hardt | Buy | Buy | Maintain | Sep 30, 2024 |
| Rosenblatt | Buy | Buy | Maintain | Sep 26, 2024 |
| Baird | Outperform | Outperform | Maintain | Sep 26, 2024 |
| Loop Capital | Buy | Buy | Maintain | Aug 6, 2024 |
| Truist Securities | Buy | Buy | Maintain | Aug 1, 2024 |
| Roth MKM | Buy | Buy | Maintain | Aug 1, 2024 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 1, 2024 |
| TD Cowen | Buy | Buy | Maintain | Jul 10, 2024 |
| Argus Research | Buy | Buy | Maintain | Aug 1, 2023 |
| China Renaissance | Buy | Hold | Upgrade | Jul 28, 2023 |
| HSBC | Hold | Reduce | Upgrade | Jul 27, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 27, 2023 |
| New Street Research | Buy | Neutral | Upgrade | Jul 25, 2023 |
| Huber Research | Overweight | Neutral | Upgrade | Apr 27, 2023 |
| OTR Global | Positive | Mixed | Upgrade | Apr 11, 2023 |
| Edward Jones | Buy | Hold | Upgrade | Mar 20, 2023 |
| Arete Research | Sell | Neutral | Downgrade | Mar 6, 2023 |
| MKM Partners | Buy | Buy | Maintain | Jan 20, 2023 |
| Itau BBA | Outperform | Market Perform | Upgrade | Nov 7, 2022 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Oct 11, 2022 |
| DZ Bank | Sell | Hold | Downgrade | Jul 29, 2022 |
| KGI Securities | Neutral | Outperform | Downgrade | Feb 8, 2022 |
Named analyst price targets
Upside is calculated against the persisted current price $728.08. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Monness | Brian White | $830 | $751.66 | +14.0% | Sep 28, 2026 |
| Canaccord Genuity | Maria Ripps | $950 | $777.59 | +30.5% | Sep 25, 2026 |
| Piper Sandler | Thomas Champion | $875 | $777.59 | +20.2% | Sep 25, 2026 |
| Jefferies | Analyst unavailable | $875 | $741.24 | +20.2% | Sep 22, 2026 |
| Wells Fargo | Ken Gawrelski | $796 | $665.75 | +9.3% | Sep 21, 2026 |
| UBS | Analyst unavailable | $775 | $571.23 | +6.4% | Aug 31, 2026 |
| Rosenblatt Securities | Barton Crockett | $886 | $576.14 | +21.7% | Aug 27, 2026 |
| Truist Financial | Youssef Squali | $763 | $576.14 | +4.8% | Aug 27, 2026 |
| Cantor Fitzgerald | Deepak Mathivanan | $680 | $534.57 | -6.6% | Jul 30, 2026 |
| Scotiabank | Nat Schindler | $600 | $585.61 | -17.6% | Jul 30, 2026 |
| Rosenblatt Securities | Barton Crockett | $883 | $585.61 | +21.3% | Jul 30, 2026 |
| Wedbush | Ygal Arounian | $595 | $585.61 | -18.3% | Jul 30, 2026 |
| Mizuho Securities | Lloyd Walmsley | $750 | $585.61 | +3.0% | Jul 30, 2026 |
| Susquehanna | Shyam Patil | $650 | $585.61 | -10.7% | Jul 30, 2026 |
| Wells Fargo | Ken Gawrelski | $640 | $585.61 | -12.1% | Jul 30, 2026 |
| Bernstein | Mark Shmulik | $800 | $585.61 | +9.9% | Jul 30, 2026 |
| Wolfe Research | Shweta Khajuria | $700 | $585.61 | -3.9% | Jul 30, 2026 |
| Goldman Sachs | Eric Sheridan | $725 | $585.61 | -0.4% | Jul 30, 2026 |
| Raymond James | Josh Beck | $850 | $645.85 | +16.7% | Jul 21, 2026 |
| Arete Research | Rocco Strauss | $735 | $600.47 | +1.0% | Jun 2, 2026 |
| Guggenheim | Michael Morris | $800 | $669.12 | +9.9% | Apr 30, 2026 |
| Cantor Fitzgerald | Deepak Mathivanan | $860 | $737.99 | +18.1% | Jan 29, 2026 |
| Piper Sandler | Thomas Champion | $880 | $721.33 | +20.9% | Jan 29, 2026 |
| Scotiabank | Nat Schindler | $700 | $719.64 | -3.9% | Jan 29, 2026 |
| KeyBanc | Analyst unavailable | $835 | $658.76 | +14.7% | Jan 26, 2026 |
| Redburn Partners | James Cordwell | $900 | $658.76 | +23.6% | Jan 26, 2026 |
| Jefferies | Analyst unavailable | $910 | $630.79 | +25.0% | Jan 22, 2026 |
| Robert W. Baird | Colin Sebastian | $815 | $661.5 | +11.9% | Dec 23, 2025 |
| Arete Research | Rocco Strauss | $718 | $639.6 | -1.4% | Dec 4, 2025 |
| BNP Paribas | Analyst unavailable | $800 | $594.25 | +9.9% | Nov 24, 2025 |
| Cantor Fitzgerald | Deepak Mathivanan | $830 | $662.96 | +14.0% | Oct 30, 2025 |
| RBC Capital | Brad Erickson | $810 | $661.57 | +11.3% | Oct 30, 2025 |
| D.A. Davidson | Analyst unavailable | $825 | $653.33 | +13.3% | Oct 30, 2025 |
| Truist Financial | Youssef Squali | $875 | $662.96 | +20.2% | Oct 30, 2025 |
| Rosenblatt Securities | Barton Crockett | $1,117 | $658.42 | +53.4% | Oct 30, 2025 |
| Raymond James | Josh Beck | $825 | $751.67 | +13.3% | Oct 30, 2025 |
| Mizuho Securities | Analyst unavailable | $925 | $743.4 | +27.0% | Sep 29, 2025 |
| Truist Financial | Analyst unavailable | $880 | $772.66 | +20.9% | Sep 18, 2025 |
| Canaccord Genuity | Maria Ripps | $850 | $704.99 | +16.7% | Jul 16, 2025 |
| Tigress Financial | Analyst unavailable | $935 | $719.8 | +28.4% | Feb 11, 2025 |
| Argus Research | Analyst unavailable | $775 | $704.19 | +6.4% | Feb 4, 2025 |
| Piper Sandler | Analyst unavailable | $670 | $647.49 | -8.0% | Jan 24, 2025 |
| RBC Capital | Analyst unavailable | $700 | $647.49 | -3.9% | Jan 24, 2025 |
| JMP Securities | Analyst unavailable | $750 | $599.24 | +3.0% | Jan 2, 2025 |
| Raymond James | Analyst unavailable | $675 | $565.11 | -7.3% | Nov 25, 2024 |
| Scotiabank | Nat Schindler | $583 | $591.8 | -19.9% | Oct 31, 2024 |
| D.A. Davidson | Gil Luria | $700 | $591.8 | -3.9% | Oct 31, 2024 |
| Citigroup | Ronald Josey | $705 | $591.8 | -3.2% | Oct 31, 2024 |
| Goldman Sachs | Eric Sheridan | $636 | $591.8 | -12.6% | Oct 30, 2024 |
| Evercore ISI | Mark Mahaney | $600 | $578.16 | -17.6% | Oct 28, 2024 |
| Bank of America Securities | Justin Post | $630 | $582.01 | -13.5% | Oct 22, 2024 |
| Mizuho Securities | James Lee | $650 | $576.79 | -10.7% | Oct 17, 2024 |
| Cantor Fitzgerald | Deepak Mathivanan | $670 | $586.27 | -8.0% | Oct 16, 2024 |
| Stifel Nicolaus | Mark Kelley | $663 | $590.42 | -8.9% | Oct 14, 2024 |
| Pivotal Research | Jeffrey Wlodarczak | $780 | $572.44 | +7.1% | Oct 1, 2024 |
| Oppenheimer | Jason Helfstein | $615 | $567.84 | -15.5% | Sep 26, 2024 |
| Citigroup | Ronald Josey | $645 | $568.31 | -11.4% | Sep 26, 2024 |
| Bank of America Securities | Justin Post | $563 | $561.35 | -22.7% | Sep 23, 2024 |
| D.A. Davidson | Gil Luria | $600 | $501.81 | -17.6% | Sep 10, 2024 |
| Cantor Fitzgerald | Deepak Mathivanan | $660 | $520.7 | -9.4% | Sep 5, 2024 |
| Wolfe Research | Shweta Khajuria | $630 | $515.48 | -13.5% | Aug 28, 2024 |
| Loop Capital Markets | Alan Gould | $575 | $499.18 | -21.0% | Aug 6, 2024 |
| Truist Financial | Youssef Squali | $570 | $494.38 | -21.7% | Aug 1, 2024 |
| Wells Fargo | Ken Gawrelski | $625 | $530.69 | -14.2% | Jul 8, 2024 |
| Wedbush | Scott Devitt | $570 | $530.72 | -21.7% | Jul 8, 2024 |
| BMO Capital | Brian Pitz | $450 | $508.84 | -38.2% | Jun 12, 2024 |
| Loop Capital Markets | Alan Gould | $550 | $434.58 | -24.5% | May 1, 2024 |
| Roth Capital | Rohit Kulkarni | $510 | $437.87 | -30.0% | Apr 25, 2024 |
| UBS | Lloyd Walmsley | $575 | $440.58 | -21.0% | Apr 25, 2024 |
| Piper Sandler | Thomas Champion | $545 | $434.3 | -25.1% | Apr 25, 2024 |
| Oppenheimer | Jason Helfstein | $500 | $493.5 | -31.3% | Apr 25, 2024 |
| KeyBanc | Justin Patterson | $475 | $493.5 | -34.8% | Apr 25, 2024 |
| Rosenblatt Securities | Barton Crockett | $562 | $493.5 | -22.8% | Apr 25, 2024 |
| Robert W. Baird | Colin Sebastian | $500 | $493.5 | -31.3% | Apr 25, 2024 |
| MoffettNathanson | Michael Nathanson | $520 | $493.5 | -28.6% | Apr 25, 2024 |
| RBC Capital | Brad Erickson | $570 | $493.5 | -21.7% | Apr 25, 2024 |
| Jefferies | Brent Thill | $540 | $493.5 | -25.8% | Apr 25, 2024 |
| Bernstein | Mark Shmulik | $565 | $493.5 | -22.4% | Apr 25, 2024 |
| Stifel Nicolaus | Mark Kelley | $550 | $493.5 | -24.5% | Apr 25, 2024 |
| Wolfe Research | Deepak Mathivanan | $500 | $493.5 | -31.3% | Apr 25, 2024 |
| Barclays | Ross Sandler | $520 | $493.5 | -28.6% | Apr 25, 2024 |
| JMP Securities | Andrew Boone | $525 | $493.5 | -27.9% | Apr 25, 2024 |
| Goldman Sachs | Eric Sheridan | $555 | $493.5 | -23.8% | Apr 24, 2024 |
| Evercore ISI | Mark Mahaney | $550 | $493.5 | -24.5% | Apr 24, 2024 |
| RBC Capital | Brad Erickson | $600 | $493.5 | -17.6% | Apr 24, 2024 |
| Truist Financial | Youssef Squali | $550 | $499.76 | -24.5% | Apr 17, 2024 |
| Piper Sandler | Thomas Champion | $600 | $519.83 | -17.6% | Apr 11, 2024 |
| Piper Sandler | Thomas Champion | $525 | $519.25 | -27.9% | Apr 9, 2024 |
| Oppenheimer | Jason Helfstein | $585 | $527.34 | -19.7% | Apr 8, 2024 |
| Jefferies | Brent Thill | $585 | $506.74 | -19.7% | Apr 4, 2024 |
| Wells Fargo | Ken Gawrelski | $600 | $497.37 | -17.6% | Apr 3, 2024 |
| Mizuho Securities | James Lee | $575 | $496.98 | -21.0% | Mar 18, 2024 |
| Morgan Stanley | Brian Nowak | $550 | $491.83 | -24.5% | Mar 14, 2024 |
| Guggenheim | Michael Morris | $520 | $478.52 | -28.6% | Feb 2, 2024 |
| Needham | Laura Martin | $160 | $394.85 | -78.0% | Jan 31, 2024 |
| Mizuho Securities | James Lee | $470 | $369.67 | -35.4% | Jan 11, 2024 |
| BMO Capital | Brian Pitz | $397 | $356.86 | -45.5% | Jan 9, 2024 |
| Wedbush | Scott Devitt | $420 | $353.96 | -42.3% | Jan 2, 2024 |
| Wedbush | Matt Bryson | $600 | $335.04 | -17.6% | Nov 20, 2023 |
| Goldman Sachs | Eric Sheridan | $384 | $284.21 | -47.3% | Oct 26, 2023 |
| Citigroup | Ronald Josey | $385 | $305.24 | -47.1% | Oct 25, 2023 |
| Mizuho Securities | James Lee | $400 | $314.69 | -45.1% | Oct 13, 2023 |
| Truist Financial | Youssef Squali | $390 | $303.89 | -46.4% | Oct 2, 2023 |
| Morgan Stanley | Brian Nowak | $375 | $299.27 | -48.5% | Sep 7, 2023 |
| JMP Securities | Andrew Boone | $380 | $322.71 | -47.8% | Aug 1, 2023 |
| Truist Financial | Youssef Squali | $340 | $316.01 | -53.3% | Jul 19, 2023 |
| Credit Suisse | Stephen Ju | $361 | $310.62 | -50.4% | Jul 17, 2023 |
| Piper Sandler | Ross Sandler | $320 | $307.46 | -56.0% | Jul 12, 2023 |
| Citigroup | Ronald Josey | $360 | $287.05 | -50.6% | Jun 27, 2023 |
| Oppenheimer | Jason Helfstein | $350 | $271.44 | -51.9% | Jun 5, 2023 |
| Oppenheimer | Aaron Kessler | $287 | $240.64 | -60.6% | Apr 27, 2023 |
| RBC Capital | Brad Erickson | $225 | $212.89 | -69.1% | Apr 21, 2023 |
| Societe Generale | Raphael Dubois | $105 | $211.65 | -85.6% | Apr 10, 2023 |
| Credit Suisse | Stephen Ju | $251 | $207.84 | -65.5% | Mar 30, 2023 |
| KeyBanc | Justin Patterson | $240 | $204.17 | -67.0% | Mar 22, 2023 |
| Morgan Stanley | Brian Nowak | $250 | $200.7 | -65.7% | Mar 21, 2023 |
| Wolfe Research | Deepak Mathivanan | $230 | $193.41 | -68.4% | Mar 15, 2023 |
| Evercore ISI | Mark Mahaney | $305 | $194.02 | -58.1% | Mar 14, 2023 |
| Mizuho Securities | James Lee | $210 | $182.43 | -71.2% | Mar 13, 2023 |
| Loop Capital Markets | Analyst unavailable | $188 | $187.73 | -74.2% | Feb 8, 2023 |
| Rosenblatt Securities | Barton Crockett | $220 | $188.77 | -69.8% | Feb 2, 2023 |
| Guggenheim | Analyst unavailable | $210 | $183.16 | -71.2% | Feb 2, 2023 |
| Jefferies | Analyst unavailable | $225 | $183.1 | -69.1% | Feb 2, 2023 |
| Canaccord Genuity | Analyst unavailable | $220 | $153.12 | -69.8% | Feb 2, 2023 |
| Piper Sandler | Analyst unavailable | $215 | $153.12 | -70.5% | Feb 2, 2023 |
| Morgan Stanley | Brian Nowak | $130 | $148.97 | -82.1% | Feb 1, 2023 |
| Oppenheimer | Jason Helfstein | $145 | $114.12 | -80.1% | Dec 7, 2022 |
| Goldman Sachs | Eric Sheridan | $165 | $100.88 | -77.3% | Oct 27, 2022 |
| Citigroup | Ronald Josey | $168 | $129.82 | -76.9% | Oct 27, 2022 |
| Credit Suisse | Stephen Ju | $145 | $97.94 | -80.1% | Oct 27, 2022 |
| Bernstein | Mark Shmulik | $135 | $97.94 | -81.5% | Oct 27, 2022 |
| Credit Suisse | Stephen Ju | $145 | $97.94 | -80.1% | Oct 27, 2022 |
| Wells Fargo | Brian Fitzgerald | $165 | $97.94 | -77.3% | Oct 27, 2022 |
| Monness | Brian White | $150 | $97.94 | -79.4% | Oct 27, 2022 |
| Guggenheim | Michael Morris | $125 | $97.94 | -82.8% | Oct 27, 2022 |
| Cowen & Co. | John Blackledge | $135 | $97.94 | -81.5% | Oct 27, 2022 |
| MKM Partners | Rohit Kulkarni | $140 | $97.94 | -80.8% | Oct 27, 2022 |
| Barclays | Ross Sandler | $165 | $129.82 | -77.3% | Oct 27, 2022 |
| Bernstein | Mark Shmulik | $135 | $97.94 | -81.5% | Oct 27, 2022 |
| Wolfe Research | Deepak Mathivanan | $140 | $97.94 | -80.8% | Oct 27, 2022 |
| Rosenblatt Securities | Barton Crockett | $114 | $97.94 | -84.3% | Oct 27, 2022 |
| Wolfe Research | Deepak Mathivanan | $140 | $97.94 | -80.8% | Oct 27, 2022 |
| Morgan Stanley | Brian Nowak | $105 | $97.94 | -85.6% | Oct 27, 2022 |
| Mizuho Securities | James Lee | $160 | $97.94 | -78.0% | Oct 27, 2022 |
| Guggenheim | Michael Morris | $125 | $97.94 | -82.8% | Oct 27, 2022 |
| RBC Capital | Brad Erickson | $150 | $97.94 | -79.4% | Oct 27, 2022 |
| Deutsche Bank | Benjamin Black CFA | $125 | $97.94 | -82.8% | Oct 27, 2022 |
| Jefferies | Brent Thill | $155 | $97.94 | -78.7% | Oct 27, 2022 |
| Susquehanna | Shyam Patil | $140 | $97.94 | -80.8% | Oct 27, 2022 |
| JMP Securities | Andrew Boone | $150 | $97.94 | -79.4% | Oct 27, 2022 |
| Mizuho Securities | James Lee | $160 | $129.82 | -78.0% | Oct 27, 2022 |
| Cowen & Co. | John Blackledge | $135 | $97.94 | -81.5% | Oct 27, 2022 |
| Truist Financial | Youssef Squali Squali | $240 | $136.41 | -67.0% | Sep 30, 2022 |
| Morgan Stanley | Brian Nowak | $225 | $168.02 | -69.1% | Aug 19, 2022 |
| JMP Securities | Andrew Boone | $160 | $158.13 | -78.0% | Jul 28, 2022 |
| Loop Capital Markets | Justin Patterson | $196 | $169.58 | -73.1% | Jul 28, 2022 |
| Wolfe Research | Deepak Mathivanan | $200 | $169.58 | -72.5% | Jul 28, 2022 |
| Credit Suisse | Stephen Ju | $214 | $169.58 | -70.6% | Jul 28, 2022 |
| Barclays | Ross Sandler | $250 | $169.58 | -65.7% | Jul 28, 2022 |
| Truist Financial | Youssef Squali | $260 | $169.58 | -64.3% | Jul 28, 2022 |
| RBC Capital | Brad Erickson | $190 | $169.58 | -73.9% | Jul 28, 2022 |
| JMP Securities | Andrew Boone | $215 | $169.58 | -70.5% | Jul 28, 2022 |
| Rosenblatt Securities | Barton Crockett | $156 | $169.58 | -78.6% | Jul 28, 2022 |
| Piper Sandler | Thomas Champion | $190 | $169.58 | -73.9% | Jul 28, 2022 |
| Mizuho Securities | James Lee | $225 | $169.58 | -69.1% | Jul 28, 2022 |
| Deutsche Bank | Benjamin Black CFA | $200 | $169.58 | -72.5% | Jul 28, 2022 |
| Credit Suisse | Stephen Ju | $245 | $175.76 | -66.3% | Jul 19, 2022 |
| Evercore ISI | Mark Mahaney | $280 | $164.7 | -61.5% | Jul 16, 2022 |
| Cowen & Co. | John Blackledge | $275 | $163.7 | -62.2% | Jul 13, 2022 |
| JMP Securities | Andrew Boone | $240 | $160.03 | -67.0% | Jul 5, 2022 |
| Truist Financial | Youssef Squali | $320 | $155.42 | -56.0% | Jul 1, 2022 |
| UBS | Lloyd Walmsley | $215 | $161.25 | -70.5% | Jun 30, 2022 |
| Goldman Sachs | Eric Sheridan | $290 | $175.57 | -60.2% | Jun 11, 2022 |
| Piper Sandler | Thomas Champion | $220 | $196.64 | -69.8% | Jun 8, 2022 |
| Morgan Stanley | Brian Nowak | $300 | $194.25 | -58.8% | Jun 7, 2022 |
| Jefferies | Brent Thill | $310 | $183.83 | -57.4% | May 26, 2022 |
| Guggenheim | Michael Morris | $250 | $191.63 | -65.7% | May 19, 2022 |
| HSBC | Nicolas Cote-Colisson | $200 | $191.64 | -72.5% | May 12, 2022 |
| Evercore ISI | Mark Mahaney | $325 | $200.47 | -55.4% | Apr 30, 2022 |
| JMP Securities | Andrew Boone | $265 | $206.96 | -63.6% | Apr 28, 2022 |
| Loop Capital Markets | Justin Patterson | $280 | $199.4 | -61.5% | Apr 28, 2022 |
| Credit Suisse | Analyst unavailable | $273 | $174.95 | -62.5% | Apr 28, 2022 |
| Raymond James | Analyst unavailable | $290 | $174.95 | -60.2% | Apr 28, 2022 |
| BMO Capital | Daniel Salmon | $222 | $174.95 | -69.5% | Apr 28, 2022 |
| BMO Capital | Daniel Salmon | $222 | $205.73 | -69.5% | Apr 28, 2022 |
| Deutsche Bank | Benjamin Black CFA | $265 | $205.73 | -63.6% | Apr 28, 2022 |
| Monness | Brian White | $300 | $205.73 | -58.8% | Apr 28, 2022 |
| Rosenblatt Securities | Barton Crockett | $212 | $205.73 | -70.9% | Apr 28, 2022 |
| Robert W. Baird | Colin Sebastian | $275 | $205.73 | -62.2% | Apr 28, 2022 |
| Jefferies | Brent Thill | $330 | $205.73 | -54.7% | Apr 28, 2022 |
| FBN Securities | Shebly Seyrafi | $270 | $205.73 | -62.9% | Apr 28, 2022 |
| Susquehanna | Shyam Patil | $290 | $205.73 | -60.2% | Apr 28, 2022 |
| MKM Partners | Rohit Kulkarni | $295 | $205.73 | -59.5% | Apr 28, 2022 |
| Wedbush | Ygal Arounian | $220 | $205.73 | -69.8% | Apr 28, 2022 |
| KeyBanc | Justin Patterson | $280 | $205.73 | -61.5% | Apr 28, 2022 |
| Wells Fargo | Brian Fitzgerald | $325 | $205.73 | -55.4% | Apr 28, 2022 |
| Piper Sandler | Thomas Champion | $230 | $174.95 | -68.4% | Apr 28, 2022 |
| Morgan Stanley | Brian Nowak | $330 | $174.95 | -54.7% | Apr 28, 2022 |
| Wolfe Research | Deepak Mathivanan | $280 | $205.73 | -61.5% | Apr 28, 2022 |
| JMP Securities | Andrew Boone | $265 | $205.73 | -63.6% | Apr 28, 2022 |
| Credit Suisse | Stephen Ju | $272 | $181.37 | -62.6% | Apr 26, 2022 |
| Evercore ISI | Mark Mahaney | $350 | $180.95 | -51.9% | Apr 26, 2022 |
| Mizuho Securities | Analyst unavailable | $325 | $184.11 | -55.4% | Apr 25, 2022 |
| BMO Capital | Daniel Salmon | $225 | $184.11 | -69.1% | Apr 24, 2022 |
| Citigroup | Analyst unavailable | $300 | $217.31 | -58.8% | Apr 20, 2022 |
| Rosenblatt Securities | Analyst unavailable | $228 | $217.46 | -68.7% | Apr 19, 2022 |
| UBS | Lloyd Walmsley | $300 | $222.33 | -58.8% | Apr 10, 2022 |
| Jefferies | Brent Thill | $350 | $224.85 | -51.9% | Apr 3, 2022 |
| Deutsche Bank | Benjamin Black | $265 | $187.61 | -63.6% | Mar 12, 2022 |
| Piper Sandler | Thomas Champion | $240 | $190.29 | -67.0% | Mar 8, 2022 |
| Morgan Stanley | Brian Nowak | $325 | $208.11 | -55.4% | Mar 2, 2022 |
| Evercore ISI | Mark Mahaney | $350 | $216.54 | -51.9% | Feb 16, 2022 |
| Tigress Financial | Ivan Feinseth | $466 | $232 | -36.0% | Feb 9, 2022 |
| Stifel Nicolaus | Mark Kelley | $350 | $232 | -51.9% | Feb 9, 2022 |
| KGI Securities | Freddy Chen | $270 | $220.18 | -62.9% | Feb 8, 2022 |
| Monness | Brian White | $375 | $237.09 | -48.5% | Feb 5, 2022 |
| China Renaissance Securities (US) Inc. | Ella Ji | $280 | $237.09 | -61.5% | Feb 4, 2022 |
| DZ BANK AG | Ingo Wermann | $225 | $237.09 | -69.1% | Feb 4, 2022 |
| Loop Capital Markets | Alan Gould | $230 | $237.76 | -68.4% | Feb 3, 2022 |
| Truist Financial | Youssef Squali | $350 | $237.76 | -51.9% | Feb 3, 2022 |
| Wedbush | Ygal Arounian | $270 | $237.76 | -62.9% | Feb 3, 2022 |
| Bank of America Securities | Justin Post | $333 | $237.76 | -54.3% | Feb 3, 2022 |
| Goldman Sachs | Eric Sheridan | $355 | $237.76 | -51.2% | Feb 3, 2022 |
| J.P. Morgan | Doug Anmuth | $284 | $237.76 | -61.0% | Feb 3, 2022 |
| JMP Securities | Ronald Josey | $350 | $237.76 | -51.9% | Feb 3, 2022 |
| Susquehanna | Shyam Patil | $375 | $237.76 | -48.5% | Feb 3, 2022 |
| Credit Suisse | Stephen Ju | $336 | $237.76 | -53.9% | Feb 3, 2022 |
| Wolfe Research | Deepak Mathivanan | $320 | $237.76 | -56.0% | Feb 3, 2022 |
| Atlantic Equities | James Cordwell | $360 | $237.76 | -50.6% | Feb 3, 2022 |
| KeyBanc | Justin Patterson | $280 | $237.76 | -61.5% | Feb 3, 2022 |
| FBN Securities | Shebly Seyrafi | $300 | $237.76 | -58.8% | Feb 3, 2022 |
| Oppenheimer | Jason Helfstein | $375 | $237.76 | -48.5% | Feb 3, 2022 |
| Citigroup | Jason Bazinet | $330 | $237.76 | -54.7% | Feb 3, 2022 |
| Canaccord Genuity | Maria Ripps | $360 | $237.76 | -50.6% | Feb 3, 2022 |
| BMO Capital | Daniel Salmon | $290 | $237.76 | -60.2% | Feb 3, 2022 |
| Wells Fargo | Brian Fitzgerald | $350 | $237.76 | -51.9% | Feb 3, 2022 |
| Cowen & Co. | John Blackledge | $330 | $237.76 | -54.7% | Feb 3, 2022 |
| Barclays | Ross Sandler | $350 | $237.76 | -51.9% | Feb 3, 2022 |
| MoffettNathanson | Michael Nathanson | $380 | $237.76 | -47.8% | Feb 3, 2022 |
| Bernstein | Mark Shmulik | $350 | $237.76 | -51.9% | Feb 3, 2022 |
| Robert W. Baird | Colin Sebastian | $325 | $323 | -55.4% | Feb 2, 2022 |
| Mizuho Securities | James Lee | $425 | $323 | -41.6% | Feb 2, 2022 |
| RBC Capital | Brad Erickson | $400 | $294.63 | -45.1% | Jan 26, 2022 |
| Guggenheim | Michael Morris | $365 | $294.63 | -49.9% | Jan 26, 2022 |
| Morgan Stanley | Brian Nowak | $395 | $303.17 | -45.7% | Jan 23, 2022 |
| Loop Capital Markets | Alan Gould | $380 | $334.2 | -47.8% | Dec 21, 2021 |
| HSBC | Nicolas Cote Colisson | $300 | $317.87 | -58.8% | Dec 6, 2021 |
Track every rating change on META the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMeta Platforms Inc., which operated as Facebook, Inc. until its October 2021 rebranding, is a technology enterprise focused on developing innovative products that empower people globally to connect and share with their friends and family. These services are accessible across a variety of digital platforms, including mobile phones, personal computers, virtual reality devices, and wearables. The company's activities are organized into two principal divisions: the Family of Apps and Reality Labs. The Family of Apps segment encompasses well-known platforms such as: Facebook, where users can share content, participate in discussions, explore new interests, and build connections.…
Historical context
All META earningsLatest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the META recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-03T17:10:43.094202+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-03T17:10:43.091306+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-03. For educational purposes only; not investment advice.